Fibromyalgia

AI Insight

This article from the New England Journal of Medicine provides a clinical review of fibromyalgia, a chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive difficulties. The review covers current understanding of pathophysiology, which involves central sensitization and altered pain processing in the nervous system, along with evidence-based approaches to diagnosis and management including both pharmacological treatments (such as pregabalin, duloxetine, and milnacipran) and non-pharmacological interventions like exercise, cognitive behavioral therapy, and patient education.

Why it matters

Fibromyalgia affects approximately 2-4% of the population, predominantly women, and significantly impacts quality of life and healthcare utilization. This comprehensive review provides clinicians with updated guidance for recognizing and treating a condition that has historically been misunderstood and undertreated in medical practice.